Macular patterns of neuronal and visual field loss in recovered optic neuritis identified by machine learning
- PMID: 39730673
- PMCID: PMC11680678
- DOI: 10.1038/s41598-024-81835-8
Macular patterns of neuronal and visual field loss in recovered optic neuritis identified by machine learning
Abstract
We used machine learning to investigate the residual visual field (VF) deficits and macula retinal ganglion cell (RGC) thickness loss patterns in recovered optic neuritis (ON). We applied archetypal analysis (AA) to 377 same-day pairings of 10-2 VF and optical coherence tomography (OCT) macula images from 93 ON eyes and 70 normal fellow eyes ≥ 90 days after acute ON. We correlated archetype (AT) weights (total weight = 100%) of VFs and total retinal thickness (TRT), inner retinal thickness (IRT), and macular ganglion cell-inner plexiform layer (GCIPL) thickness. AA showed most ON eyes had a 10-2 VF pattern like the normal fellow eye VF, despite having markedly thinner GCIPL patterns. AA identified 7 VF and 11 retinal thickness ATs for each OCT model. The normal VF AT constituted 80% of ON eyes and 90% of normal fellow eyes. The most common GCIPL AT consisted of diffuse thinning. We identified significant correlations for the normal AT weights using OCT AT weights of five GCIPL ATs (r = 0.45), four TRT ATs (0.53) and two IRT ATs (0.42). Following acute ON, most eyes had complete 10-2 VF recovery despite significant GCIPL thinning, suggesting compensatory mechanisms for vision.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures







References
-
- Optic Neuritis Study Group. The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial. Neurology49 (5), 1404–1413 (1997). - PubMed
-
- Trobe, J. D., Beck, R. W., Moke, P. S. & Cleary, P. A. Contrast sensitivity and other vision tests in the optic neuritis treatment trial. Am. J. Ophthalmol.121 (5), 547–553 (1996). - PubMed
-
- Beck, R. W. et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl. J. Med.326 (9), 581–588 (1992). - PubMed
-
- Keltner, J. L. et al. Baseline visual field profile of optic neuritis: the experience of the Optic Neuritis Treatment Trial. Arch. Ophthalmol.111 (2), 231–234 (1993). - PubMed
MeSH terms
Grants and funding
- I01 RX003797/RX/RRD VA/United States
- I50 RX003002; VA RR&D I01RX003797/Department of Veteran Affairs (VA) Center for the Prevention and Treatment of Visual Loss, Rehabilitation Research and Development (RR&D)
- R01 EY015473/EY/NEI NIH HHS/United States
- NEI R01 EY015473/Research to Prevent Blindness, Inc., New York, NY unrestricted grant to the Department of Ophthalmology
- NEI EY032522/The New York Eye and Ear Infirmary Foundation, New York, N.Y
LinkOut - more resources
Full Text Sources
Miscellaneous